Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

More nitric oxide synthase inhibitors from Japan Tobacco

Aug. 9, 1996

Nitric oxide synthase inhibitors described by Hoechst

Aug. 9, 1996

FDA clears Mylan's nicardipine HCl

Aug. 9, 1996

UCB reports alpha-adrenergic ligands with cardiovascular activity

Aug. 9, 1996

Biovail's diltiazem covered under U.S. patent

Aug. 9, 1996

Status update of Recordati's lercanidipine HCl

Aug. 9, 1996

SmithKline Beecham and Meiji Seika to comarket levcromakalim

Aug. 9, 1996

Eisai terminates E-4177 development

Aug. 9, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026